Structural basis for the interaction of TAK1 kinase with its activating protein TAB1

Kieron Brown1, Sarah C M Vial, Neesha Dedi

  • 1Vertex Pharmaceuticals (Europe) Ltd, 88 Milton Park, Abingdon, Oxfordshire OX14 4RY, UK.

Insights

Transforming growth factor-beta (TGF-beta)-activated kinase 1 (TAK1) requires TAK1-binding protein 1 (TAB1) for activation. Crystal structures reveal TAB1 binds TAK1 via a novel pocket, explaining their molecular interaction.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-beta)-activated kinase 1 (TAK1) is a MAPKKK family protein kinase.
  • TAK1 mediates intracellular signaling pathways activated by TGF-beta, interleukin-1, and tumor necrosis factor-alpha.
  • TAK1 requires TAK1-binding protein 1 (TAB1) for full activation, but the mechanism remains unclear.

Purpose of the Study:

  • To elucidate the molecular basis of TAK1 activation by TAB1.
  • To provide structural insights into the interaction between TAK1 and TAB1.

Main Methods:

  • Solved the crystal structure of a novel TAK1 chimeric protein.
  • Analyzed the structural basis of the TAK1-TAB1 interaction.

Main Results:

  • Identified a novel binding pocket on the TAK1 kinase domain.
  • Discovered a unique alpha-helix in the TAB1 binding domain.
  • Revealed an intimate hydrophobic association between TAK1 and TAB1, explaining the activation mechanism.

Conclusions:

  • The crystal structure provides a molecular explanation for TAB1-mediated TAK1 activation.
  • The findings highlight a specific hydrophobic interaction crucial for the protein activator-target relationship.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...